Χώρα: Ηνωμένο Βασίλειο
Γλώσσα: Αγγλικά
Πηγή: MHRA (Medicines & Healthcare Products Regulatory Agency)
Dexamethasone sodium phosphate
Glenmark Pharmaceuticals Europe Ltd
H02AB02
Dexamethasone sodium phosphate
8mg
Soluble tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 06030200; GTIN: 05060204163456
PACKAGE LEAFLET: INFORMATION FOR THE USER GLENSOLUDEX 2 MG, 4 MG AND 8 MG SOLUBLE TABLETS DEXAMETHASONE IMPORTANT INFORMATION ABOUT THIS MEDICINE GLENSOLUDEX IS A STEROID MEDICINE , prescribed for many different conditions including serious illnesses YOU NEED TO TAKE IT REGULARLY to get the maximum benefit DON’T STOP TAKING THIS MEDICINE without talking to your doctor – you may need to reduce the dose gradually GLENSOLUDEX CAN CAUSE SIDE EFFECTS IN SOME PEOPLE (read Section 4: Possible side effects). Some problems such as mood changes (feeling depressed, or ‘high’), or stomach problems can happen straight away. If you feel unwell, in any way, keep taking your medicine, BUT SEE YOUR DOCTOR STRAIGHT AWAY SOME SIDE EFFECTS ONLY HAPPEN AFTER WEEKS OR MONTHS . These include weakness of arms and legs, or developing a rounder face (read Section 4 for more information) IF YOU TAKE IT FOR MORE THAN 3 WEEKS YOU WILL GET A ‘STEROID CARD’ : always keep it with you and show it to any doctor or nurse treating you KEEP AWAY FROM PEOPLE WHO HAVE CHICKEN POX, SHINGLES OR MEASLES , if you have never had them. They could affect you severely. If you do come into contact with chicken pox or shingles, SEE YOUR DOCTOR STRAIGHT AWAY NOW READ THE REST OF THIS LEAFLET. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects talk to your doctor or pharmacist. This includes any side effects not listed in this leaflet. What is in this leaflet: 1. What Glensoludex soluble tablets is and what it is used for 2. What you need to know before you take Glensoludex soluble tablets 3. How to take Glensoludex soluble tablets 4. Possible side- Διαβάστε το πλήρες έγγραφο
OBJECT 1 GLENSOLUDEX 8 MG SOLUBLE TABLETS Summary of Product Characteristics Updated 07-Jan-2021 | Glenmark Pharmaceuticals Europe Ltd • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Glensoludex 8 mg soluble tablets 2. Qualitative and quantitative composition Each tablet contains 8 mg dexamethasone as dexamethasone sodium phosphate. The sodium content of Glensoludex 8 mg soluble tablets is 60.5 mg per tablet. For a full list of excipients, see section 6.1 3. Pharmaceutical form Soluble tablet Glensoludex Soluble tablets 8 mg are salmon, biconvex, engraved '8', round tablets 4. Clinical particulars 4.1 Therapeutic indications Glensoludex is indicated for use in certain endocrine and non-endocrine disorders, in certain cases of cerebral oedema and for diagnostic testing of adrenocortical hyperfunction. Endocrine disorders: Endocrine exophthalmos. Non-endocrine disorders: Glensoludex may be used in the treatment of non-endocrine corticosteroid responsive conditions includin Διαβάστε το πλήρες έγγραφο